KDELR1

gene
On this page

Also known as ERD2.1ERD2HDEL

Summary

KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1, HGNC:6304) is a protein-coding gene on chromosome 19q13.33, encoding ER lumen protein-retaining receptor 1 (P24390). Receptor for the C-terminal sequence motif K-D-E-L that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the Golgi back to the endoplasmic reticulum.

Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi, or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells, and his-asp-glu-leu (HDEL) in S. cerevisiae. This process is mediated by a receptor that recognizes, and binds the tetrapeptide-containing protein, and returns it to the ER. In yeast, the sorting receptor encoded by a single gene, ERD2, which is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. The protein encoded by this gene was the first member of the family to be identified, and it encodes a protein structurally and functionally similar to the yeast ERD2 gene product.

Source: NCBI Gene 10945 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 26 total
  • Druggable target: yes
  • MANE Select transcript: NM_006801

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6304
Approved symbolKDELR1
NameKDEL endoplasmic reticulum protein retention receptor 1
Location19q13.33
Locus typegene with protein product
StatusApproved
AliasesERD2.1, ERD2, HDEL
Ensembl geneENSG00000105438
Ensembl biotypeprotein_coding
OMIM131235
Entrez10945

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 2 retained_intron

ENST00000330720, ENST00000594643, ENST00000597017, ENST00000599084, ENST00000600980, ENST00000932964, ENST00000932965, ENST00000943172

RefSeq mRNA: 1 — MANE Select: NM_006801 NM_006801

CCDS: CCDS12718

Canonical transcript exons

ENST00000330720 — 5 exons

ExonStartEnd
ENSE000007174794838423048384482
ENSE000011313654838955348389711
ENSE000011313884839126848391551
ENSE000012508734838257548383327
ENSE000036360444839042448390524

Expression profiles

Bgee: expression breadth ubiquitous, 273 present calls, max score 98.88.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 255.6435 / max 1673.8309, expressed in 1827 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
181843253.13181827
1818422.51181299

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
parotid glandUBERON:000183198.88gold quality
stromal cell of endometriumCL:000225598.85gold quality
left ovaryUBERON:000211998.47gold quality
right ovaryUBERON:000211898.33gold quality
endometrium epitheliumUBERON:000481198.33gold quality
endocervixUBERON:000045898.26gold quality
saliva-secreting glandUBERON:000104498.16gold quality
pylorusUBERON:000116698.08gold quality
right lobe of thyroid glandUBERON:000111998.03gold quality
minor salivary glandUBERON:000183098.03gold quality
mucosa of transverse colonUBERON:000499198.03gold quality
tendon of biceps brachiiUBERON:000818898.02gold quality
left lobe of thyroid glandUBERON:000112098.01gold quality
superficial temporal arteryUBERON:000161498.01gold quality
right coronary arteryUBERON:000162598.00gold quality
rectumUBERON:000105297.99gold quality
body of pancreasUBERON:000115097.98gold quality
cardia of stomachUBERON:000116297.98gold quality
body of stomachUBERON:000116197.95gold quality
adenohypophysisUBERON:000219697.95gold quality
islet of LangerhansUBERON:000000697.94gold quality
gall bladderUBERON:000211097.94gold quality
olfactory segment of nasal mucosaUBERON:000538697.94gold quality
right adrenal glandUBERON:000123397.93gold quality
transverse colonUBERON:000115797.89gold quality
left adrenal glandUBERON:000123497.89gold quality
renal medullaUBERON:000036297.88gold quality
left uterine tubeUBERON:000130397.87gold quality
left adrenal gland cortexUBERON:003582597.87gold quality
right adrenal gland cortexUBERON:003582797.87gold quality

Single-cell (SCXA)

Detected in 9 experiment(s), a significant marker in 8.

ExperimentMarker?Max mean expression
E-CURD-88yes81.49
E-HCAD-4yes46.46
E-CURD-122yes37.67
E-HCAD-10yes27.06
E-ANND-3yes22.01
E-CURD-46yes19.72
E-MTAB-10042yes10.92
E-MTAB-10553yes9.74
E-HCAD-13no3.02

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

72 targeting KDELR1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4713-3P100.0065.92505
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548AN99.9770.912817
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-6825-5P99.9669.813431
HSA-LET-7C-3P99.9573.422862
HSA-MIR-185-3P99.9567.011743
HSA-MIR-96-5P99.9572.802140
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-1213399.9271.822006
HSA-MIR-1271-5P99.9171.991972
HSA-MIR-368699.9070.532432
HSA-MIR-427199.8868.322244
HSA-MIR-182-5P99.8774.032589
HSA-MIR-548D-3P99.8770.674362

Literature-anchored findings (GeneRIF, showing 15)

  • the KDEL receptor participates in the ER stress response not only by its retrieval ability but also by modulating MAP kinase signaling (PMID:12821650)
  • Src relocated the KDEL receptor (KDEL-R) from the Golgi apparatus to the endoplasmic reticulum (PMID:12975382)
  • our data provide evidence that KDELR, as a novel inducer of autophagy, participates in the degradation of misfolded neurodegenerative disease-related proteins. (PMID:21684323)
  • Cystinosin, MPDU1, SWEETs and KDELR belong to a well-defined protein family with putative function of cargo receptors. (PMID:22363504)
  • These findings reveal an unexpected GPCR-like mode of action of the KDEL-R and shed light on a core molecular control mechanism of intra-Golgi traffic. (PMID:22580821)
  • It discuss the particular role of KDEL receptor signaling in the regulation of important pathways involved in the maintenance of the homeostasis of the transport apparatus, and in particular, of the Golgi complex. (PMID:23873287)
  • KDEL receptor activates CREB1 and other transcription factors that upregulate transport-related genes (PMID:25117681)
  • A Golgi-based KDELR-dependent signalling pathway controls invadopodia-dependent extracellular matrix degradation. (PMID:25682866)
  • We propose a model whereby in analogy to previous findings (e.g., the RAS-RAF signalling pathway), PHB can act as a signalling scaffold protein to assist in KDELR-dependent Src activation (PMID:26064897)
  • KDELR protein mediated the intracellular trafficking of Japanese encephalitis virus particles. (PMID:26861384)
  • Data show that Golgi-based, KDEL receptor-dependent signalling promotes lysosome repositioning to the perinuclear area, involving a complex process intertwined to autophagy, lipid-droplet turnover and Golgi-mediated secretion. (PMID:30760704)
  • The cell surface trafficking of PDIA1, PDIA3, and PDIA6 is dependent on KDELR1, which travels in a dynamic manner to the cell surface. This transport is assumed to result in PDI cell surface association, which differs from PDI inducible secretion into the extracellular space. (PMID:30958660)
  • Transcriptomics of a KDELR1 knockout cell line reveals modulated cell adhesion properties. (PMID:31337861)
  • KDEL receptor is a cell surface receptor that cycles between the plasma membrane and the Golgi via clathrin-mediated transport carriers. (PMID:32562023)
  • Cell-type-specific differences in KDEL receptor clustering in mammalian cells. (PMID:32645101)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusKdelr1ENSMUSG00000002778
rattus_norvegicusKdelr1ENSRNOG00000021082
drosophila_melanogasterKdelRFBGN0267330
caenorhabditis_elegansWBGENE00001331
caenorhabditis_elegansWBGENE00016195

Paralogs (2): KDELR3 (ENSG00000100196), KDELR2 (ENSG00000136240)

Protein

Protein identifiers

ER lumen protein-retaining receptor 1P24390 (reviewed: P24390)

Alternative names: KDEL endoplasmic reticulum protein retention receptor 1, Putative MAPK-activating protein PM23

All UniProt accessions (2): P24390, M0R1Y2

UniProt curated annotations — full annotation on UniProt →

Function. Receptor for the C-terminal sequence motif K-D-E-L that is present on endoplasmic reticulum resident proteins and that mediates their recycling from the Golgi back to the endoplasmic reticulum.

Subunit / interactions. Upon ligand binding the receptor oligomerizes and interacts with components of the transport machinery such as ARFGAP1 and ARF1.

Subcellular location. Golgi apparatus membrane. Cytoplasmic vesicle. COPI-coated vesicle membrane. Endoplasmic reticulum membrane. Endoplasmic reticulum-Golgi intermediate compartment membrane.

Post-translational modifications. Phosphorylation by PKA at Ser-209 is required for endoplasmic reticulum retention function.

Domain organisation. Binds the C-terminal sequence motif K-D-E-L in a hydrophilic cavity between the transmembrane domains. This triggers a conformation change that exposes a Lys-rich patch on the cytosolic surface of the protein. This patch mediates recycling from the Golgi to the endoplasmic reticulum, probably via COPI vesicles.

Similarity. Belongs to the ERD2 family.

Isoforms (2)

UniProt IDNamesCanonical?
P24390-11yes
P24390-22

RefSeq proteins (1): NP_006792* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000133ER_ret_rcptFamily

Pfam: PF00810

UniProt features (34 total): mutagenesis site 10, topological domain 8, transmembrane region 7, region of interest 3, site 3, chain 1, modified residue 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P24390-F192.660.84

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 5 (interaction with the k-d-e-l motif on target proteins); 117 (interaction with the k-d-e-l motif on target proteins); 193 (important for recycling of cargo proteins with the sequence motif k-d-e-l from the golgi to the endoplasmic reticulum)

Post-translational modifications (1): 209

Mutagenesis-validated functional residues (10):

PositionPhenotype
12loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
32decreased binding to the sequence motif k-d-e-l.
47loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
91–92decreased binding to the sequence motif k-d-e-l.
127loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
158loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
193loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
204–207loss of recycling together with cargo proteins containing the sequence motif k-d-e-l from the golgi to the endoplasmic r
209inhibits coatomer/arf-gap recruitment, receptor redistribution, and intracellular retention of kdel ligands.
209redistribution to the er is not affected upon pka inactivation.

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6807878COPI-mediated anterograde transport
R-HSA-6811434COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-9918476Assembly and Release of Dengue Virus Virions

MSigDB gene sets: 213 (showing top): MORF_MTA1, RNGTGGGC_UNKNOWN, SWEET_KRAS_ONCOGENIC_SIGNATURE, TTTGTAG_MIR520D, SP3_Q3, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM, GOBP_MAINTENANCE_OF_LOCATION, MORF_RAB6A, GOCC_COATED_VESICLE, GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE, GOCC_GOLGI_ASSOCIATED_VESICLE, GOBP_LEUKOCYTE_APOPTOTIC_PROCESS

GO Biological Process (6): protein retention in ER lumen (GO:0006621), retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), protein transport (GO:0015031), T cell differentiation (GO:0030217), T cell apoptotic process (GO:0070231), vesicle-mediated transport (GO:0016192)

GO Molecular Function (3): KDEL sequence binding (GO:0005046), ER lumen protein retrieval receptor activity (GO:0046923), protein binding (GO:0005515)

GO Cellular Component (11): Golgi membrane (GO:0000139), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), cis-Golgi network (GO:0005801), transport vesicle (GO:0030133), COPI-coated vesicle membrane (GO:0030663), endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116), Golgi apparatus (GO:0005794), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
ER to Golgi Anterograde Transport1
Golgi-to-ER retrograde transport1
Dengue Virus Infection1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm4
intracellular membrane-bounded organelle4
endomembrane system3
transport2
Golgi apparatus2
bounding membrane of organelle2
maintenance of protein localization in endoplasmic reticulum1
Golgi vesicle transport1
intracellular protein localization1
establishment of protein localization1
lymphocyte differentiation1
T cell activation1
lymphocyte apoptotic process1
cellular process1
ER lumen protein retrieval receptor activity1
signal sequence receptor activity1
binding1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
cytoplasmic vesicle1
COPI-coated vesicle1
Golgi-associated vesicle membrane1
coated vesicle membrane1
endoplasmic reticulum-Golgi intermediate compartment1
cellular anatomical structure1
intracellular vesicle1

Protein interactions and networks

STRING

1118 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KDELR1SDF2L1Q9HCN8866
KDELR1SDF2Q99470848
KDELR1RCN1Q15293840
KDELR1COPB1P53618832
KDELR1RCN2Q14257819
KDELR1GOLPH3Q9H4A6799
KDELR1RER1O15258692
KDELR1SURF4O15260683
KDELR1SEC63Q9UGP8635
KDELR1POMT2Q9UKY4607
KDELR1POMT1Q9Y6A1582
KDELR1PREBQ9HCU5576
KDELR1SEC13P55735565
KDELR1SEC61A1P38378551
KDELR1CALRP27797523

IntAct

84 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:0914”(association)0.710
CFTRHAX1psi-mi:“MI:0914”(association)0.610
KRT34KDELR1psi-mi:“MI:0915”(physical association)0.560
KDELR1DLG2psi-mi:“MI:0915”(physical association)0.560
KDELR1DLG3psi-mi:“MI:0915”(physical association)0.560
KDELR1TRAFD1psi-mi:“MI:0914”(association)0.530
APLNRSLC33A1psi-mi:“MI:0914”(association)0.530
TMEM63AAP3D1psi-mi:“MI:0914”(association)0.530
CLCC1PLSCR1psi-mi:“MI:0914”(association)0.530
LPAR1TMEM223psi-mi:“MI:0914”(association)0.530
COPB1KDELR1psi-mi:“MI:0915”(physical association)0.400
KDELR1SEC23Apsi-mi:“MI:0915”(physical association)0.400
KDELR1KDELR1psi-mi:“MI:2364”(proximity)0.380
KDELR1KDELR1psi-mi:“MI:0403”(colocalization)0.380
KDELR1CCR9psi-mi:“MI:0915”(physical association)0.370
KDELR1F2RL1psi-mi:“MI:0915”(physical association)0.370
KDELR1GPR35psi-mi:“MI:0915”(physical association)0.370
HSCBRBP5psi-mi:“MI:0914”(association)0.350
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
LRRK2psi-mi:“MI:0914”(association)0.350
KDELR1PSMD11psi-mi:“MI:0914”(association)0.350
RAC1psi-mi:“MI:0914”(association)0.350
PRKAR1AADAM10psi-mi:“MI:0914”(association)0.350
PEBP1ANXA2P2psi-mi:“MI:0914”(association)0.350
TMEM223psi-mi:“MI:0914”(association)0.350

BioGRID (128): KDELR1 (Affinity Capture-MS), UBE3A (Affinity Capture-MS), UBL7 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), VPS36 (Affinity Capture-MS), TAX1BP1 (Affinity Capture-MS), TRAFD1 (Affinity Capture-MS), UCHL5 (Affinity Capture-MS), PSMD11 (Affinity Capture-MS), UBQLN4 (Affinity Capture-MS), NPLOC4 (Affinity Capture-MS), PSMD12 (Affinity Capture-MS), PSMD6 (Affinity Capture-MS), UBQLN1 (Affinity Capture-MS), RNF115 (Affinity Capture-MS)

ESM2 similar proteins: A0A097ZPD8, A0A0E3D8M2, A0A0E3D8Q2, A0A0F7TZE0, A0A0U5GIU9, A0A140JWT2, A0A1B7YCX1, A0A1E1FFM9, A0A1Y0BRF5, A0A2I1BT01, A0A2I6PJ07, A0A2P1DP74, A0A3G9H8P0, A0A3T0ZHJ5, A0A455RAK9, A0A8D5M7T9, A9JPE3, B6HV37, E3UBL6, E9F5E8, J7FIJ6, K2RU64, M1VJS5, P0DY23, P24390, P33946, P35402, P48583, P9WEQ3, P9WEX1, P9WEX7, P9WEY0, Q0VCC1, Q15FB1, Q4WBI3, Q4WLD2, Q569A6, Q5M880, Q5U305, Q5XHA2

Diamond homologs: O42580, O43731, O44017, O76767, O94270, P18413, P18414, P24390, P33946, P33947, P33948, P35402, P48583, Q09473, Q2KJ37, Q569A6, Q5U305, Q5XHA2, Q5ZKX9, Q611C8, Q66JF2, Q68ES4, Q6P257, Q6PAB8, Q6PEH1, Q6PFS5, Q76NM1, Q7ZXS5, Q86JE5, Q8R1L4, Q8VWI1, Q99JH8, Q9CQM2, Q9ZTN2

SIGNOR signaling

1 interactions.

AEffectBMechanism
PRKACAup-regulatesKDELR1phosphorylation

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 100 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
positive regulation of cytosolic calcium ion concentration811.0×3e-04
adenylate cyclase-activating G protein-coupled receptor signaling pathway79.3×3e-03
G protein-coupled receptor signaling pathway146.0×7e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

26 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance11
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

711 predictions. Top by Δscore:

VariantEffectΔscore
19:48383323:TAGGA:Tacceptor_gain1.0000
19:48383325:GGA:Gacceptor_gain1.0000
19:48383326:GA:Gacceptor_gain1.0000
19:48383326:GAC:Gacceptor_loss1.0000
19:48383328:C:CCacceptor_gain1.0000
19:48383329:T:Cacceptor_loss1.0000
19:48383330:G:Cacceptor_gain1.0000
19:48384225:GCTAC:Gdonor_loss1.0000
19:48384226:CTACC:Cdonor_loss1.0000
19:48384227:TAC:Tdonor_loss1.0000
19:48384228:A:ATdonor_loss1.0000
19:48384229:CCTTT:Cdonor_loss1.0000
19:48389548:CCTA:Cdonor_loss1.0000
19:48389549:CTAC:Cdonor_loss1.0000
19:48389550:TA:Tdonor_loss1.0000
19:48389551:A:ATdonor_loss1.0000
19:48389708:CCAC:Cacceptor_gain1.0000
19:48389709:CACC:Cacceptor_gain1.0000
19:48389710:ACC:Aacceptor_loss1.0000
19:48389711:CCT:Cacceptor_loss1.0000
19:48389712:CTGA:Cacceptor_loss1.0000
19:48389713:T:Gacceptor_loss1.0000
19:48390421:TACCT:Tdonor_loss1.0000
19:48390422:ACC:Adonor_loss1.0000
19:48390423:CC:Cdonor_loss1.0000
19:48390525:C:Aacceptor_loss1.0000
19:48390525:C:CCacceptor_gain1.0000
19:48390533:C:CTacceptor_gain1.0000
19:48390534:A:Tacceptor_gain1.0000
19:48391286:T:TAdonor_gain1.0000

AlphaMissense

1376 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:48384284:C:GG184R1.000
19:48384368:C:GG156R1.000
19:48384436:G:CP133R1.000
19:48384436:G:TP133Q1.000
19:48391336:C:TG8E1.000
19:48384252:G:CF194L0.999
19:48384252:G:TF194L0.999
19:48384254:A:GF194L0.999
19:48384283:C:TG184D0.999
19:48384286:G:TA183E0.999
19:48384328:C:GR169P0.999
19:48384329:G:TR169S0.999
19:48384338:A:GW166R0.999
19:48384338:A:TW166R0.999
19:48384339:G:CN165K0.999
19:48384339:G:TN165K0.999
19:48384358:C:GR159P0.999
19:48384359:G:TR159S0.999
19:48384367:C:TG156D0.999
19:48384370:A:GL155P0.999
19:48384379:A:GL152S0.999
19:48384430:A:GL135P0.999
19:48384437:G:AP133S0.999
19:48384437:G:TP133T0.999
19:48384442:A:TI131N0.999
19:48384445:G:TA130D0.999
19:48384446:C:GA130P0.999
19:48384453:C:AE127D0.999
19:48384453:C:GE127D0.999
19:48384454:T:AE127V0.999

dbSNP variants (sampled 300 via entrez): RS1000125913 (19:48392020 G>A), RS1000319960 (19:48397051 C>T), RS1000409250 (19:48392748 C>A,G,T), RS1000743486 (19:48390748 A>C), RS1000817332 (19:48386117 T>C), RS1000984746 (19:48397615 T>C), RS1001059588 (19:48396158 T>A,C), RS1001122510 (19:48383445 T>A,C,G), RS1001215324 (19:48384627 C>T), RS1001594456 (19:48395912 TG>T), RS1001627022 (19:48396129 A>G), RS1001698775 (19:48391868 G>C), RS1001778538 (19:48396802 G>A), RS1001800324 (19:48391755 CTG>C), RS1001964026 (19:48395288 C>G,T)

Disease associations

OMIM: gene MIM:131235 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066272 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

2 potent at pChembl≥5 of 4 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
9.60Kd0.253nMCHEMBL5653589
9.60ED500.253nMCHEMBL5653589

PubChem BioAssay actives

1 with measured affinity, of 4 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2148618: Binding affinity to human KDELR1 incubated for 45 mins by Kinobead based pull down assaykd0.0003uM

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
GSK-J4increases expression1
ginger extractaffects cotreatment, affects expression, increases abundance1
alpha-pineneincreases abundance, affects cotreatment, increases oxidation1
bisphenol Aaffects cotreatment, affects expression, increases abundance1
deoxynivalenoldecreases expression1
arseniteaffects binding, increases reaction1
sodium arseniteincreases expression1
cobaltous chloridedecreases expression1
methacrylaldehydeaffects cotreatment, increases oxidation, increases abundance1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
U 0126affects expression, affects reaction1
bisphenol Bincreases expression1
abrinedecreases expression1
Bortezomibdecreases expression1
Temozolomideincreases expression1
Decitabineaffects methylation1
Sunitinibdecreases expression1
Vorinostatdecreases expression1
Acroleinincreases abundance, affects cotreatment, increases oxidation1
Air Pollutantsincreases oxidation, affects cotreatment, increases abundance1
Arsenicincreases methylation1
Benzo(a)pyreneaffects methylation1
Diazinonincreases methylation1
Ivermectindecreases expression1
Methotrexateaffects response to substance1
Oils, Volatileaffects cotreatment, affects expression, increases abundance1
Ozoneaffects cotreatment, increases oxidation, increases abundance1
Phthalic Acidsdecreases methylation1
Smokedecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5651660BindingBinding affinity to human KDELR1 incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Cellosaurus cell lines

3 cell lines: 2 cancer cell line, 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2ZKAbcam HEK293T KDELR1 KOTransformed cell lineFemale
CVCL_SU14HAP1 KDELR1 (-) 1Cancer cell lineMale
CVCL_XP95HAP1 KDELR1 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.